JOHN MOSTAFA

Podiatric Medicine & Surgery Service Providers|Podiatrist|Foot & Ankle Surgery BRICK, NJ NPI 1598058554

General Payments — all program years on this page

$25,765.33

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 177
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,859.26 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $4,613.009
Food and Beverage $246.269

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BIOTISSUE HOLDINGS INC. $4,751.8811
Paratek Pharmaceuticals, Inc. $92.416
TREACE MEDICAL CONCEPTS, INC. $14.971

By program year

Program yearAmountRecords
2018 $13,067.6057
2019 $3,910.2233
2020 $596.5716
2021 $2,316.4732
2022 $607.8713
2023 $407.348
2024 $4,859.2618

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1113911247 Paratek Pharmaceuticals, Inc. $13.83 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113911249 Paratek Pharmaceuticals, Inc. $18.18 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113911251 Paratek Pharmaceuticals, Inc. $15.03 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113911253 Paratek Pharmaceuticals, Inc. $13.92 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113911255 Paratek Pharmaceuticals, Inc. $13.55 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113911257 Paratek Pharmaceuticals, Inc. $17.90 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148747280 BIOTISSUE HOLDINGS INC. $478.20 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148749338 BIOTISSUE HOLDINGS INC. $478.20 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148749960 BIOTISSUE HOLDINGS INC. $2,251.20 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148749962 BIOTISSUE HOLDINGS INC. $264.00 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148753792 BIOTISSUE HOLDINGS INC. $30.00 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148753794 BIOTISSUE HOLDINGS INC. $30.00 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148753796 BIOTISSUE HOLDINGS INC. $478.20 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148753798 BIOTISSUE HOLDINGS INC. $478.20 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148779717 BIOTISSUE HOLDINGS INC. $17.79 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148779811 BIOTISSUE HOLDINGS INC. $121.09 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148788823 BIOTISSUE HOLDINGS INC. $125.00 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1151440765 TREACE MEDICAL CONCEPTS, INC. $14.97 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.